Moreover, a study examining the clinical data, routine blood counts, and responses to granulocyte-colony stimulating factor therapy from 88 affected BTHS boys concluded that susceptibility to infections was due only in part to neutropenia since in some instances infection occurred despite consistent prevention of neutropenia by granulocyte-colony-stimulating factor therapy [9]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.